Overview
Wen Jiang is a primary care provider, practicing in Family Medicine in Edison, New Jersey. Dr. Jiang is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Cerebral Hypoxia and Triple-Negative Breast Cancer.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Ivy Chung is a primary care provider, practicing in Family Medicine in Commack, New York. Dr. Chung is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Hypothyroidism, Chronic Cough, High Cholesterol, and Autism Spectrum Disorder.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaDr. Jiang isExperienced. Learn about Cerebral Hypoxia.
- Triple-Negative Breast CancerDr. Jiang isExperienced. Learn about Triple-Negative Breast Cancer.